【Jefferies-2025研报】日本兴和制药(4547):具有低风险的诱人增长潜力,升级为买入.pdf

【Jefferies-2025研报】日本兴和制药(4547):具有低风险的诱人增长潜力,升级为买入.pdf

Japan|Pharmaceuticals

EquityResearch

KisseiPharmaceuticalMay29,2025

AttractiveGrowthPotentialwithLowRisk,RATING|TARGET|

ESTIMATE

CHANGE

UpgradingtoBuy

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档